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Neuromyelitis optica (NMO), or Devic’s disease, is an idiopathic severe demyelinating disease of the central nervous system (CNS) that preferentially 
affects the optic nerve and spinal cord. It has long been 
considered a “more severe form” of multiple sclerosis (MS). 
However, recent evidence suggests that NMO is an entirely 
separate entity, because an antibody to aquaporin-4, a water 
channel found on CNS astrocytes,1 has been identified as a 
unique biomarker for the disease.
While provision of labor analgesia2 or neuraxial anes-
thesia for cesarean delivery in women with MS is widely 
accepted,3 the safety of neuraxial anesthesia in NMO has 
not been established. Spinal anesthesia has even been sug-
gested to cause NMO, although this is highly debated.4,5 
With new insights into the pathophysiology of NMO, the 
effects of neuraxial techniques on women with NMO are of 
increased interest because more women of childbearing age 
are likely to be diagnosed with this disease in the future.
We report the anesthetic care of a morbidly obese pri-
migravida woman, managed with a spinal anesthetic, 
requiring a cesarean delivery at 32 weeks due to an acute 
exacerbation of NMO.
The patient’s informed consent was obtained for case 
report publication.
CASE DESCRIPTION
A 22-year-old G1P0 woman of mixed Asian and African 
American origin with a 3-year history of NMO presented at 
13 weeks’ gestation. She was diagnosed with NMO in 2009 
when she presented with blindness and lower extremity 
weakness. On initial workup, she was found to have optic 
neuritis, transverse myelitis, and met all supportive criteria 
for NMO (Table  1). Magnetic resonance imaging (MRI) at 
that time (Fig. 1) revealed intramedullary lesions in the cer-
vical and thoracic spinal cord that had resolved with aggres-
sive treatment of her NMO (prednisone and azathioprine), 
as seen on her 2010 MRI (Fig.  2). Since her 2010 MRI, she 
had been managed with azathioprine only. In addition, the 
patient was morbidly obese (body mass index = 45 kg/m2), 
with poorly controlled type 2 diabetes mellitus.
She was admitted for treatment of flares of NMO at 21, 
24, 28, and 29 weeks’ gestation. Her symptoms included 
severe generalized body itching, excruciating allodynia in 
which she could not tolerate the touch of any clothes includ-
ing the hospital patient gown, and profound bilateral lower 
extremity weakness, preventing ambulation. Her first 3 
flares were successfully treated with IV methylprednisolone 
and plasmapheresis. However, on her 4th admission at 29 
weeks, symptoms continued to worsen despite IV methyl-
prednisolone, plasma exchanges, IV immunoglobulin, and 
azathioprine. With no resolution of symptoms at 32 weeks, 
a decision was made to proceed with a planned cesarean 
delivery. With additional consultation from the neurolo-
gist managing her NMO flares, the anesthesiology team 
concluded that neuraxial approaches were not contraindi-
cated in this patient, despite her worsening sensory–motor 
deficits.
After informing the patient of all the risks and complica-
tions of a general anesthetic, spinal anesthetic, a combined 
spinal–epidural, or even continuous spinal anesthesia, the 
patient agreed with our plan to proceed with spinal anes-
thesia after understanding the risks and benefits of each 
approach and also understanding that we may have to 
emergently convert the spinal anesthetic to a general anes-
thetic. Two 18-gauge IV catheters (BD Insyte Autogard 
TM, Becton Dickinson, Sandy, UT) and an arterial catheter 
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Table 1.  Diagnostic Criteria for Neuromyelitis Optica6,7
Definitely required criteria
  Optic neuritis
  Acute myelitis
At least 2 of 3 supportive criteria
Contiguous spinal cord MRI lesion extending over >3 vertebral 
segments
Brain MRI not meeting diagnostic criteria for multiple sclerosis
NMO-IgG seropositive status
NMO = neuromyelitis optica; MRI = magnetic resonance imaging; 
IgG = immunoglobulin G.
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(Arrow Quickflash Radial Artery Catherization set, Arrow 
International, Reading, PA) were inserted. Using a 25-gauge 
Whitacre needle inserted at a presumed L4-5 level, a solu-
tion of hyperbaric bupivacaine (12 mg), fentanyl (15 mcg), 
and preservative-free morphine (200 mcg) was injected 
into the subarachnoid space. A phenylephrine infusion was 
started at 50 mcg/min at the time of spinal injection. The 
obstetricians proceeded with the cesarean delivery after a 
bilateral T4 level of insensibility to pinprick was achieved. 
While the patient did not discern the initial skin incision and 
dissection, manipulation of the uterus caused intense pain 
and burning in the abdominal area. IV fentanyl (85 mcg), 
morphine (2 mg), and midazolam (2 mg) were given to alle-
viate her symptoms, but were completely ineffective. As a 
last resort before inducing general anesthesia, inhaled 50% 
nitrous oxide was administered with complete resolution of 
burning sensations and all discomfort. An otherwise healthy 
premature male infant, weighing 1.6 kg with Apgar scores 
of 6 and 7 at 1 and 5 minutes, respectively, was delivered. 
The patient recovered from the spinal anesthetic within 3 to 
4 hours. The baby was taken to the neonatal intensive care 
unit after birth and was discharged home 2 months later. 
The patient was started on a rituximab infusion 2 days after 
delivery followed by tapering of the steroid dose.
An MRI performed 72 hours after delivery showed new 
intramedullary lesions from C3-5 and C7 compared with 
her previous MRI in 2010, consistent with a demyelinat-
ing process (Fig. 3). Neurologic symptoms rapidly resolved 
over the course of 7 days, and the patient was discharged 
for rehabilitation 8 days after the delivery.
The patient was contacted 1 year postpartum. She 
reported no residual neurological deficits other than minor 
periumbilical numbness. She had recovered her ability to 
walk and had no allodynia.
DISCUSSION
Devic first described this disease as a purely monophasic 
disease with 2 defining symptoms, bilateral visual loss and 
myelitis.8 As these 2 clinical symptoms often presented 
together, this disease later became known as NMO. NMO is 
relatively rare with an unknown incidence and prevalence. 
Specific diagnostic criteria were only established in 2006 
Figure 1. Sagittal spine magnetic resonance image (MRI) T2 with 
short time inversion recovery (STIR) sequence showing demyelin-
ation at C2-3 at the time of diagnosis of this patient. 
Figure 2. Sagittal spine magnetic resonance image (MRI) T2 with 
short time inversion recovery (STIR) sequence (2010), showing reso-
lution (no lesions) of her 2009 flare.
Figure 3. Sagittal spine magnetic resonance image (MRI) T2 with 
short time inversion recovery (STIR) sequence showing recurrence 
of the disease during pregnancy in 2012.
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(Table 1). NMO is likely to represent <1% of all CNS demy-
elinating diseases in the Caucasian population, but 20% to 
48% of CNS demyelinating disease in certain  non-Caucasian 
populations, particularly in Asia and Africa.9 NMO appears 
to be more common in women.10 The disease has a relaps-
ing form, approximately 80% of those affected are women.10
NMO has long been thought to be a variant form of MS. 
However, recent studies have shown that while symptoms 
of the 2 diseases can be similar, their pathophysiologies 
are substantially different.8 Subsequently, the treatments, 
mostly immunomodulatory, for NMO and MS are distinct. 
Some treatments that are successful for MS are likely to 
worsen NMO and the inverse is true as well.10 In addition, 
while MS exacerbations decrease in frequency during preg-
nancy,11 exacerbations of NMO have been shown to increase 
in frequency in the parturient.12
Our patient’s symptoms appear to have been exacerbated 
by pregnancy and relieved after delivery. One of her main 
complaints was that of severe allodynia in the abdominal 
area, leading to the decision to perform a preterm scheduled 
cesarean delivery. After adminstering  the spinal anesthetic, 
despite an adequate bilateral surgical anesthesia to the T4 
dermatomal level, and blockade of somatic pain on skin inci-
sion, the patient reported severe hyperalgesic visceral pain 
that resolved completely with nitrous oxide. Nitrous oxide 
has been shown to prevent opioid tolerance in the periopera-
tive setting, possibly by its N-methyl-d-aspartate antagonistic 
activity.13 We can speculate that in the setting of a demyelin-
ating condition such as NMO, there seems to be abnormal 
peripheral and central sensitization causing chronic pain or 
abnormal pain sensation such as allodynia (like this patient 
had), nitrous oxide could then be particularly effective as an 
analgesic in this disease. Ketamine may have provided the 
same effect. However, due to the immediate and striking 
response to nitrous oxide, ketamine was not administered.
There are few published reports describing the use of 
neuraxial anesthesia in obstetric patients with NMO. Two 
case reports describe the use of epidural anesthesia in the 
NMO obstetric population. One describes the management 
of an urgent cesarean delivery with an epidural anesthetic 
for a nonreassuring fetal heart tracing at 37 weeks’ gesta-
tion in a woman previously diagnosed with NMO, with no 
postoperative complications.14 The other reports a patient 
with NMO who developed temporary neurological symp-
toms 2 months after an epidural anesthetic causing that 
patient to elect a general anesthetic for her subsequent 
delivery, which was done with no postoperative complica-
tions.15 Two case reports4,5 describe development of NMO 
1 to 2 days after spinal anesthesia with ensuing permanent 
neurological deficits, 1 in a parturient who had a cesarean 
delivery4 and 1 in an older woman undergoing orthope-
dic surgery.5 One retrospective cohort study from France 
using an NMO registry tracked 20 women with a total of 25 
pregnancies and found that the course of the disease was 
similar in women who delivered with epidural analgesia 
and those who did not.12
These various anecdotal reports seem to have examined 2 
separate questions. First, is there an association between neur-
axial anesthesia in a previously healthy patient and NMO, or 
in other words, could a spinal anesthetic unmask or precipitate 
NMO in an individual who has not yet been diagnosed with 
the disease? Second, what is the best anesthetic management 
for a parturient diagnosed with NMO and potentially under-
going surgery or requesting labor analgesia at the time of a 
flare? The second question is more relevant to our case, and 
because the major concerns are that neuraxial techniques may 
cause an exacerbation of NMO, until more spinal anesthetics 
are delivered in patients with NMO, we cannot conclude that 
this technique is safe for all patients with NMO.
The impressive response of our patient to the analgesic 
effect of nitrous oxide was striking, suggesting that nitrous 
oxide could be an advantageous adjuvant for patients with 
allodynia in the context of a demyelinating disease. Further 
reports and outcomes of spinal anesthesia in parturients 
diagnosed with NMO will be of interest since one can antici-
pate that more women with this diagnosis will be managed 
by obstetric anesthesiologists. E
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